Related Experiment Videos

Sentinel lymph node biopsy and adjuvant therapy for melanoma: evidence revisited

Kelly M McMasters, Arthur Sober, John M Kirkwood

Archives of Dermatology

|January 21, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Evidence of genetic susceptibility to immune-related dermatitis in patients with melanoma treated with immune checkpoint inhibitors.

Melanoma research·2026

Durable stable disease and immune activation in metastatic uveal melanoma treated with tebentafusp: case report.

Frontiers in immunology·2026

Nectin-4 as predictive biomarker of immune-related adverse event subtypes in adjuvant anti-programmed-death-1 treatment of melanoma.

Melanoma research·2026

Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.

Nature communications·2026

Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.

JCO oncology practice·2026

Purinergic activity of circulating extracellular vesicles associates with disease progression in melanoma.

Oncoimmunology·2026

See all related articles